. 1999.
“Discontinuation Of Anticytomegalovirus Therapy In Patients With Hiv Infection And Cytomegalovirus Retinitis.”. Jama 282 (17). Jama: 1633-7. doi:10.1001/jama.282.17.1633.
. 1999. “Treatment Of Noninfectious Intermediate And Posterior Uveitis With The Humanized Anti-Tac Mab: A Phase I/ii Clinical Trial”. Proceedings Of The National Academy Of Science Usa 96. Proceedings Of The National Academy Of Science Usa: 7462-66.
. 1999. “Treatment Of Noninfectious Intermediate And Posterior Uveitis With The Humanized Anti-Tac Mab: A Phase I/ii Clinical Trial.”. Proc Natl Acad Sci U S A 96 (13). Proc Natl Acad Sci U S A: 7462-6. doi:10.1073/pnas.96.13.7462.
. 1999. “Conjunctiva T-Cell Subpopulations In Jorgen’S And Non-Jorgen’S Patients With Dry Eye”. Invest Ophthalmol Vis Sci 43. Invest Ophthalmol Vis Sci: 2609-2614.
. 2002. “Decreased Risk Of Renal Allograft Thrombosis Associated With Interleukin-2 Receptor Antagonists: A Report Of The Naprtcs”. Am J Transplant 6. Am J Transplant: 585-588. http://www.ncbi.nlm.nih.gov/pubmed/16468970.
. 2006. “Contributions Of The Transplant Registry: The 2006 Annual Report Of The North American Pediatric Renal Trials And Collaborative Studies (Naprtcs)”. Pediatr Transplant 11. Pediatr Transplant: 366-373. http://www.ncbi.nlm.nih.gov/pubmed/17493215.
. 2007. “Incidence Of Ptld In Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus And Steroids”. Am J Transplant 8. Am J Transplant: 984-989. http://www.ncbi.nlm.nih.gov/pubmed/18416737.
. 2008. “Association Between Clinical Risk Factors And Progression Of Chronic Kidney Disease In Children”. Clin J Am Soc Nephrol 5. Clin J Am Soc Nephrol: 2172-2179. http://www.ncbi.nlm.nih.gov/pubmed/20813855.
. 2010.